Gut Microbiota-Based Immunotherapy: Engineered <i>Escherichia coli</i> Nissle 1917 for Oral Delivery of Glypican-1 in Pancreatic Cancer
<i>Background and Objectives</i>: The administration of oral vaccines offers a potential strategy for cancer immunotherapy; yet, the development of effective platforms continues to pose a difficulty. This study examines <i>Escherichia coli</i> Nissle 1917 (EcN) as a microbial...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-03-01
|
| Series: | Medicina |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1648-9144/61/4/633 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Be the first to leave a comment!